ARUL M CHINNAIYAN
Medical Practice in Ann Arbor, MI
License number
Michigan 4301074630
Issued Date
Jan 8, 2002
Expiration Date
Jan 31, 2018
Category
Medicine
Type
Medical Doctor
Address
Address
Ann Arbor, MI 48109
Professional information
Professor Of Pathology
Position:
Professor of Pathology and Urology at HHMI, S.P. Hicks Endowed Professor of Pathology at University of Michigan Health System
Location:
Greater Detroit Area
Industry:
Biotechnology
Work:
HHMI
- Ann Arbor, MI since Feb 2008
-
Professor of Pathology and Urology
University of Michigan Health System
- Ann Arbor, MI since Jan 2001
-
S.P. Hicks Endowed Professor of Pathology
Education:
University of Michigan 1988 - 1999
BS, MD, PhD, Medicine
BS, MD, PhD, Medicine
Diagnosis And Treatment Of Breast Cancer
US Patent:
2008020, Aug 28, 2008
Filed:
Nov 8, 2007
Appl. No.:
11/936871
Inventors:
Arul Chinnaiyan - Ann Arbor MI, US
Scott Tomlins - Ann Arbor MI, US
Daniel Rhodes - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Scott Tomlins - Ann Arbor MI, US
Daniel Rhodes - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 31/41, G01N 33/68, A61P 35/00
US Classification:
514381, 436 64
Abstract:
The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to AGTR1 and LBP markers for breast cancer.
Recurrent Gene Fusions In Prostate Cancer
US Patent:
2012029, Nov 22, 2012
Filed:
May 30, 2012
Appl. No.:
13/483142
Inventors:
Scott Tomlins - Ann Arbor MI, US
Daniel Rhodes - Ann Arbor MI, US
Arul Chinnaiyan - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Mark A. Rubin - New York NY, US
Xiao-Wei Sun - New York NY, US
Sven Perner - Ellwaugen, DE
Charles Lee - Marlborough MA, US
Francesca Demichelis - New York NY, US
Daniel Rhodes - Ann Arbor MI, US
Arul Chinnaiyan - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Mark A. Rubin - New York NY, US
Xiao-Wei Sun - New York NY, US
Sven Perner - Ellwaugen, DE
Charles Lee - Marlborough MA, US
Francesca Demichelis - New York NY, US
Assignee:
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. - Boston MA
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
C07K 16/18
US Classification:
5303897
Abstract:
Recurrent gene fusions of androgen regulated genes and ETS family member genes in prostate cancer are described. Compositions and methods having utility in prostate cancer diagnosis, research, and therapy are also provided.
Recurrent Gene Fusions In Prostate Cancer
US Patent:
8580509, Nov 12, 2013
Filed:
May 30, 2012
Appl. No.:
13/483176
Inventors:
Scott Tomlins - Ann Arbor MI, US
Daniel Rhodes - Ann Arbor MI, US
Arul Chinnaiyan - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Mark A. Rubin - New York NY, US
Xiao-Wei Sun - New York NY, US
Sven Perner - Ellwaugen, DE
Charles Lee - Marlborough MA, US
Francesca Demichelis - New York NY, US
Daniel Rhodes - Ann Arbor MI, US
Arul Chinnaiyan - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Mark A. Rubin - New York NY, US
Xiao-Wei Sun - New York NY, US
Sven Perner - Ellwaugen, DE
Charles Lee - Marlborough MA, US
Francesca Demichelis - New York NY, US
Assignee:
The Regents of The University of Michigan - Ann Arbor MI
The Brigham and Women's Hospital, Inc. - Boston MA
The Brigham and Women's Hospital, Inc. - Boston MA
International Classification:
C12Q 1/68, C12P 19/34, C07H 21/02, C07H 21/04
US Classification:
435 612, 435 912, 435810, 536 221, 536 243
Abstract:
Recurrent gene fusions of androgen regulated genes and ETS family member genes in prostate cancer are described. Compositions and methods having utility in prostate cancer diagnosis, research, and therapy are also provided.
Recurrent Gene Fusions In Prostate Cancer
US Patent:
2013004, Feb 14, 2013
Filed:
May 30, 2012
Appl. No.:
13/483157
Inventors:
Scott Tomlins - Ann Arbor MI, US
Daniel Rhodes - Ann Arbor MI, US
Arul Chinnaiyan - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Mark A. Rubin - New York NY, US
Xiao-Wei Sun - New York NY, US
Sven Perner - Ellwaugen, DE
Charles Lee - Marlborough MA, US
Francesca Demichelis - New York NY, US
Daniel Rhodes - Ann Arbor MI, US
Arul Chinnaiyan - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Mark A. Rubin - New York NY, US
Xiao-Wei Sun - New York NY, US
Sven Perner - Ellwaugen, DE
Charles Lee - Marlborough MA, US
Francesca Demichelis - New York NY, US
Assignee:
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. - Boston MA
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
C40B 40/06, C07H 21/04
US Classification:
506 16, 536 2431, 536 234
Abstract:
Recurrent gene fusions of androgen regulated genes and ETS family member genes in prostate cancer are described. Compositions and methods having utility in prostate cancer diagnosis, research, and therapy are also provided.
Recurrent Gene Fusions In Prostate Cancer
US Patent:
8211645, Jul 3, 2012
Filed:
Dec 30, 2009
Appl. No.:
12/650164
Inventors:
Scott Tomlins - Ann Arbor MI, US
Daniel Rhodes - Ann Arbor MI, US
Arul Chinnaiyan - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Mark A. Rubin - New York NY, US
Xiao-Wei Sun - New York NY, US
Sven Perner - Ellwaugen, DE
Charles Lee - Marlborough MA, US
Francesca Demichelis - New York NY, US
Daniel Rhodes - Ann Arbor MI, US
Arul Chinnaiyan - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Mark A. Rubin - New York NY, US
Xiao-Wei Sun - New York NY, US
Sven Perner - Ellwaugen, DE
Charles Lee - Marlborough MA, US
Francesca Demichelis - New York NY, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
The Brigham and Women's Hospital - Boston MA
The Brigham and Women's Hospital - Boston MA
International Classification:
C12Q 1/68, C12P 19/34, C07H 21/04
US Classification:
435 612, 435 912, 435810, 536 221, 536 243
Abstract:
Recurrent gene fusions of androgen regulated genes and ETS family member genes in prostate cancer are described. Compositions and methods having utility in prostate cancer diagnosis, research, and therapy are also provided.